Form 4: National Healthcare Corp Director Gifts Shares, Maintains Substantial Holdings
Insider Ownership Change
National Healthcare Corp Director Richard F. LaRoche Jr. reported gifting 152 shares of common stock on June 3, 2025, while retaining significant direct and indirect holdings, including various stock options.
Summary
- Richard F. LaRoche Jr., a Director of National Healthcare Corp (NHC), reported a change in beneficial ownership via a Form 4 filing.
- On June 3, 2025, Mr. LaRoche disposed of 152 shares of common stock through a gift (transaction code 'G').
- The reported price for the disposed shares was $104.69 per share, which represents the market value at the time of the gift.
- Following this transaction, Mr. LaRoche beneficially owns 205,760 shares of National Healthcare Corp common stock directly.
- The filing also details Mr. LaRoche's derivative holdings, which include 37,500 options to purchase common stock across five separate grants (2021, 2022, 2023, 2024, and 2025).
- Each option grant is for 7,500 shares, with exercise prices ranging from $55.75 to $96.03.
- The expiration dates for these options range from May 5, 2026, to May 7, 2030.
Sentiment
Score: 7
Explanation: The filing indicates a routine insider transaction (gift) by a director, which does not suggest any negative sentiment towards the company. The director retains a substantial stake, indicating continued confidence and alignment with shareholder interests.
Positives
- The disposition of shares was a gift, not a sale, which typically does not signal a negative outlook on the company's future performance.
- The director, Richard F. LaRoche Jr., maintains a substantial beneficial ownership of 205,760 common shares, indicating continued alignment with shareholder interests and confidence in the company.
Negatives
- A minor reduction in the director's direct beneficial ownership due to the gift of 152 shares.
Future Outlook
NA
Industry Context
NA
Stakeholder Impact
- Shareholders: The gift of a small number of shares results in minor dilution, but the director's continued substantial holding of 205,760 common shares and 37,500 stock options indicates ongoing alignment of interests with other shareholders.
- Employees: No direct impact on employees is indicated by this filing.
- Customers: No direct impact on customers is indicated by this filing.
- Suppliers: No direct impact on suppliers is indicated by this filing.
- Creditors: No direct impact on creditors is indicated by this filing.
Key Dates
| Date | Description |
|---|---|
| 05/06/2022 | Date exercisable for 2021 stock option grant |
| 05/05/2023 | Date exercisable for 2022 stock option grant |
| 05/09/2024 | Date exercisable for 2024 stock option grant |
| 05/04/2025 | Date exercisable for 2023 stock option grant |
| 06/03/2025 | Date of common stock gift transaction |
| 06/05/2025 | Signature date of the reporting person |
| 05/05/2026 | Expiration date for 2021 stock option grant |
| 05/08/2026 | Date exercisable for 2025 stock option grant |
| 05/04/2027 | Expiration date for 2022 stock option grant |
| 05/03/2028 | Expiration date for 2023 stock option grant |
| 05/08/2029 | Expiration date for 2024 stock option grant |
| 05/07/2030 | Expiration date for 2025 stock option grant |
Recommendation
holdKeywords
National Healthcare Corp, NHC, Form 4, Insider Transaction, Stock Ownership, Director, Gift, Stock Options, Beneficial Ownership
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.